{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:30:37Z","timestamp":1758990637272},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2007,2,15]]},"DOI":"10.1007\/s00417-006-0412-5","type":"journal-article","created":{"date-parts":[[2006,11,30]],"date-time":"2006-11-30T09:21:07Z","timestamp":1164878467000},"page":"215-220","source":"Crossref","is-referenced-by-count":28,"title":["Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments"],"prefix":"10.1007","volume":"245","author":[{"given":"Fabio Bom","family":"Aggio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel Eid","family":"Farah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner Camilo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Barreto","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,12,1]]},"reference":[{"key":"412_CR1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00417-005-1177-y","volume":"243","author":"JF Arevalo","year":"2005","unstructured":"Arevalo JF, Garcia RA, Mendoza AJ (2005) Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration. Graefe\u2019s Arch Clin Exp Ophthalmol 243:1180\u20131185","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"412_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363\u2013372","journal-title":"Ophthalmology"},{"key":"412_CR3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0161-6420(02)01561-0","volume":"110","author":"BP Connoly","year":"2003","unstructured":"Connoly BP, Regillo CD, Eagle Jr RC, Shields CL, Shields JA, Moran H (2003) The histopathologic effects of transpupillary thermotherapy in human eyes. Ophthalmology 110:415\u2013420","journal-title":"Ophthalmology"},{"key":"412_CR4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1076\/ceyr.25.5.287.13496","volume":"25","author":"RA Costa","year":"2002","unstructured":"Costa RA, Scapucin L, Moraes NS, Calucci D, Melo Jr LA, Cardillo JA, Farah ME (2002) Indocyanine green-mediated photothrombosis as a new technique of treatment for persistent central serous chorioretinopathy. Curr Eye Res 25:287\u2013297","journal-title":"Curr Eye Res"},{"key":"412_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1167\/iovs.05-0354","volume":"47","author":"S Michels","year":"2006","unstructured":"Michels S, Hansmann F, Geitzenauer W, Schmidt-Erfurth (2006) Influence of treatment parameters on selectivity of verteporfin therapy. Invest Ophthalmol Vis Sci 47:371\u2013376","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"412_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","volume":"36","author":"PJ Rosenfeld","year":"2005","unstructured":"Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331\u2013335","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"412_CR7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0161-6420(03)00452-4","volume":"110","author":"UM Schmidt-Erfurth","year":"2003","unstructured":"Schmidt-Erfurth UM, Michaels S (2003) Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Ophthalmology 110:1306\u20131314","journal-title":"Ophthalmology"},{"key":"412_CR8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","volume":"26","author":"RF Spaide","year":"2006","unstructured":"Spaide RF, Laud K, Fine HF, Klancnik JM Jr, Meyerle CB, Yannuzzi LA, Sorenson J, Slakter J, Fisher YL, Cooney MJ (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383\u2013390","journal-title":"Retina"},{"key":"412_CR9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ophtha.2004.08.012","volume":"112","author":"RF Spaide","year":"2005","unstructured":"Spaide RF, Sorenson J, Maranan L (2005) Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112:301\u2013304","journal-title":"Ophthalmology"},{"key":"412_CR10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group","year":"1999","unstructured":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials\u2014TAP report 1. Arch Ophthalmol 117:1329\u20131345","journal-title":"Arch Ophthalmol"},{"key":"412_CR11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","volume":"131","author":"Verteporfin in Photodynamic Therapy (VIP) Study Group","year":"2001","unstructured":"Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization\u2014VIP report 2. Am J Ophthalmol 131:541\u2013560","journal-title":"Am J Ophthalmol"},{"key":"412_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00006982-200502000-00002","volume":"25","author":"Verteporfin Roundtable Participants","year":"2005","unstructured":"Verteporfin Roundtable Participants (2005) Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 25:119\u2013134","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0412-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-006-0412-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0412-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T08:37:52Z","timestamp":1628152672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-006-0412-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,15]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1007\/s00417-006-0412-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}